SCHEMBL19397307

SCHEMBL19397307

Cc1ccc(-c2cc(-c3ccc(-c4ccccc4)cc3)nc(C)n2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.70
MEN1 O00255 5/20 0.70
MAPT P10636 4/20 0.70
HPGD P15428 4/20 0.70
KDM4E B2RXH2 3/20 0.70
ALDH1A1 P00352 3/20 0.70
TDP1 Q9NUW8 3/20 0.70
L3MBTL1 Q9Y468 2/20 0.70
AGTR1 P30556 1/20 0.64
LMNA P02545 2/20 0.63
TP53 P04637 2/20 0.63
POLB P06746 1/20 0.63
SLC2A1 P11166 1/20 0.53
ALDH1A3 P47895 1/20 0.53
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
SREBF2 Q12772 1/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18900464 0.98 KMT2A (0.72) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL17286932 0.94 KMT2A (0.60) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL16353106 0.94 KMT2A (0.60) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL12264966 0.89 MAPT (0.59) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL10039374 0.89 KMT2A (0.60) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL19397308 0.89 MAPT (0.59) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL12628252 0.88 MEN1 (0.70) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL18731950 0.88 MEN1 (0.70) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL18562524 0.88 KMT2A (0.55) KMT2AMEN1MAPTHPGDKDM4E
SCHEMBL22373721 0.88 MEN1 (0.70) KMT2AMEN1MAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 KMT2A 3322/4885MEN1 509/4885MAPT 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.